Barclays
SHC icon

Barclays’s Sotera Health SHC Stock Holding History

Barclays’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Sell
129,622
-61,107
-32% -$1.01M ﹤0.01% 2395
2025
Q4 		$3.36M Sell
190,729
-90,366
-32% -$1.49M ﹤0.01% 2537
2025
Q3 		$4.42M Buy
281,095
+32,787
+13% +$460K ﹤0.01% 2301
2025
Q2 		$2.76M Buy
248,308
+148,431
+149% +$1.74M ﹤0.01% 2596
2025
Q1 		$1.16M Sell
99,877
-49,854
-33% -$642K ﹤0.01% 3020
2024
Q4 		$2.05M Sell
149,731
-323,866
-68% -$4.69M ﹤0.01% 2853
2024
Q3 		$7.91M Buy
473,597
+298,085
+170% +$4.35M ﹤0.01% 1658
2024
Q2 		$2.08M Sell
175,512
-81,570
-32% -$931K ﹤0.01% 2109
2024
Q1 		$3.09M Buy
257,082
+21,328
+9% +$317K ﹤0.01% 2205
2023
Q4 		$3.97M Buy
235,754
+137,404
+140% +$1.95M ﹤0.01% 2310
2023
Q3 		$1.47M Sell
98,350
-19,745
-17% -$333K ﹤0.01% 2075
2023
Q2 		$2.22M Buy
118,095
+103,322
+699% +$1.64M ﹤0.01% 1820
2023
Q1 		$265K Sell
14,773
-11,695
-44% -$195K ﹤0.01% 3643
2022
Q4 		$220K Buy
26,468
+3,297
+14% +$24.6K ﹤0.01% 3782
2022
Q3 		$158K Buy
23,171
+7,773
+50% +$129K ﹤0.01% 3336
2022
Q2 		$302K Buy
15,398
+13,863
+903% +$290K ﹤0.01% 3194
2022
Q1 		$33K Buy
+1,535
New +$32.6K ﹤0.01% 4277

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Barclays's SHC Position: Q1 2026 in Review

Barclays reduced its Sotera Health (SHC) stake by 32% in Q1 2026, selling an estimated $1.01M and leaving 129,622 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #2395.

Barclays first reported a position in SHC in Q1 2022 and has held it in 17 quarters since. The position peaked at $7.91M in Q3 2024. 299 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Barclays held 129,622 shares of Sotera Health worth $1.86M as of Q1 2026.
  • Barclays sold 61,107 Sotera Health shares in Q1 2026, an estimated $1.01M.
  • Sotera Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2395 holding.
  • Barclays first reported a position in Sotera Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Sotera Health position peaked at $7.91M in Q3 2024.
  • 299 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.